Fortress Biotech, Inc. Sustainability Profile
Fortress Biotech, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States. Founded in 2010, the company focuses on developing and commercialising innovative therapies for rare and complex diseases. With a robust portfolio of products, Fortress Biotech stands out for its unique approach to drug development, leveraging its extensive network of subsidiaries and partnerships to enhance its market position. The company operates primarily in the fields of oncology and rare diseases, with a commitment to addressing unmet medical needs. Notable achievements include the successful advancement of several drug candidates through clinical trials, showcasing its dedication to innovation and patient care. Fortress Biotech continues to solidify its reputation as a leader in the biopharmaceutical sector, driven by a mission to improve patient outcomes through cutting-edge therapies.
DitchCarbon Score
How does Fortress Biotech, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fortress Biotech, Inc.'s score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Fortress Biotech, Inc.'s reported carbon emissions
Fortress Biotech, Inc., headquartered in the US, currently does not have any reported carbon emissions data for the latest year. As such, there are no specific figures available for Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not established any documented reduction targets or climate pledges at this time. In the absence of emissions data, it is important to note that Fortress Biotech, Inc. is actively engaged in the broader industry context of climate commitments. While specific initiatives or targets are not outlined, the company is part of a growing movement within the biotechnology sector to address climate change and reduce carbon footprints. As the company continues to develop its sustainability strategies, stakeholders can anticipate future commitments that align with industry standards and best practices in climate action.
How Carbon Intensive is Fortress Biotech, Inc.'s Industry?
How Carbon Intensive is Fortress Biotech, Inc.'s Location?
Fortress Biotech, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fortress Biotech, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.